Buscar por Autor 90e40a55-c98b-4cbd-bb65-555382433888

Ir a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
O introducir las primeras letras:  
Mostrando resultados 11 a 20 de 20 < Anterior 
Vista previaFecha de publicaciónTítuloAutor(es)Acceso
Impact of CYP2D6 genotype on opioid use disorder deprescription an observational prospective study in chronic pain with sex-differences.pdf.jpg2023Impact of CYP2D6 genotype on opioid use disorder deprescription: an observational prospective study in chronic pain with sex-differences
Muriel, Javier; Barrachina, Jordi; Del Barco, Guillermo; Carvajal, Cristian; Escorial, Mónica; Margarit, César; Ballester, Purificación; Peiró, Ana María
Long-term deprescription in chronic pain and opioid use disorder patients. Pharmacogenetic and sex differences.pdf.jpg18-nov-2022Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences
Muriel, Javier; Escorial, Mónica; Margarit, César; Barrachina, Jordi; Carvajal, Cristian; Morales, Domingo; Peiró, Ana
OPRM1 influence on and effectiveness of an individualized.pdf.jpg2018OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients
Muriel, Javier; Margarit, César; Planelles, Beatriz; Serralta, María J.; Puga, Carmen; Inda, María del Mar; Cutillas, Esperanza; Morales, Domingo; Horga, José F.
Oxycodonenaloxone - naloxone versus tapentadol in real-world chronic non-cancer pain management.an observational and pharmacogenetic study.pdf.jpgjun-2022Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study
Barrachina, Jordi; Margarit, César; Muriel, Javier; López‑Gil, Santiago; López Gil, Vicente; Vara-González, Amaya; Planelles, Beatriz; Inda, María del Mar; Morales, Domingo; Peiró, Ana
Oxycodonenaloxone.naxolone  versus tapentadol in real world chronic non‑cancer pain.pdf.jpg2022Oxycodone/naloxone versus tapentadol in real‑world chronic non‑cancer pain management: an observational and pharmacogenetic study
Barrachina, Jordi; Margarit, Cesar; Muriel, Javier; López‑Gil, Santiago; López Gil, Vicente; Vara-González, Amaya; Planelles, Beatriz; Inda, María del Mar; Morales, Domingo; Peiró, Ana María
Pharmacogenetic Guided Opioid Therapy Improves Chronic.pdf.jpg2023Pharmacogenetic Guided Opioid Therapy Improves Chronic Pain Outcomes and Comorbid Mental Health: A Randomized, Double-Blind, Controlled Study
Agulló, Laura; Aguado, Isidro; Muriel, Javier; Margarit, César; Gómez, Alba; Escorial, Mónica; Sánchez, Astrid; Fernández, Alicia; Peiró, Ana
Pharmacogenetics and prediction of adverse events in.pdf.jpg2018Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patients
Muriel, Javier; Margarit, César; Barrachina, Jordi; Ballester, Purificación; Flor, Andrea; Morales, Domingo; Horga, José F.; Fernández, Eduardo; Peiró, Ana
Sex-Differences in Pain and Opioid Use Disorder Management.pdf.jpg2022Sex-Differences in Pain and Opioid Use Disorder Management: A Cross-Sectional Real-World Study
Escorial, Mónica; Muriel, Javier; César, Margarit; Laura, Agulló; Domingo, Morales; Peiró, Ana
The challenge of detecting adverse events in adults with autism.pdf.jpgmay-2021The challenge of detecting adverse events in adults with autism spectrum disorder who have intellectual disability
Ballester, Purificación; Espadas, Cristina; Londoño, Ana C.; Almenara, Susana; Aguilar, Víctor; Belda, César; Pérez, Enrique; Muriel, Javier; Peiró, Ana
Tesis Muriel Serrano, Javier.pdf.jpg26-jul-2019Tratamiento del trastorno por consumo de opioides de prescripción, en pacientes con dolor crónico no oncológico: efectividad, seguridad y marcadores farmacogenéticosMuriel, Javier